Differential Toxicities of Tyrosine Kinase Inhibitors in the Management of Metastatic Lung Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Differential Toxicities of Tyrosine Kinase Inhibitors in the Management of Metastatic Lung Cancer ; volume:38 ; number:01 ; year:2017 ; pages:15-17
Indian journal of medical & paediatric oncology ; 38, Heft 01 (2017), 15-17
- Contributor
-
Udupa, Karthik S.
Rajendranath, Rejiv
Sagar, Tenali
Thomas, Joseph
- DOI
-
10.4103/0971-5851.203502
- URN
-
urn:nbn:de:101:1-2021082711502834365623
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Udupa, Karthik S.
- Rajendranath, Rejiv
- Sagar, Tenali
- Thomas, Joseph
Other Objects (12)
Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
Differential toxicities of insecticides and halogenated aromatics
Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells
Editorial: Targeting bruton tyrosine kinase
Differential toxicities of fine particulate matters from various sources
Comparative genomics of Cylindrospermopsis raciborskii strains with differential toxicities
Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
Second-generation inhibitors of Bruton tyrosine kinase
Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
Differential toxicities of insecticides and halogenated aromatics
Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells
Editorial: Targeting bruton tyrosine kinase
Differential toxicities of fine particulate matters from various sources
Comparative genomics of Cylindrospermopsis raciborskii strains with differential toxicities
Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
Second-generation inhibitors of Bruton tyrosine kinase
Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
Differential toxicities of insecticides and halogenated aromatics
Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells
Editorial: Targeting bruton tyrosine kinase
Differential toxicities of fine particulate matters from various sources
Comparative genomics of Cylindrospermopsis raciborskii strains with differential toxicities
Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors